Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

35.64
+0.47001.34%
Post-market: 35.640.00000.00%17:08 EDT
Volume:4K
Turnover:146.92K
Market Cap:1.96M
PE:- -
High:35.64
Open:35.10
Low:35.10
Close:35.17
52wk High:36.54
52wk Low:23.88
Shares:55.00K
Float Shares:55.00K
Volume Ratio:2.21
T/O Rate:7.56%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live
·
Aug 05

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04

Alnylam Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $455 from $485

THOMSON REUTERS
·
Aug 04

Vertex Analysts Lower Their Forecasts Following Q2 Results

Benzinga Earnings
·
Aug 04

Guardant Health is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 04

Vertex Pharmaceuticals Inc : Bofa Global Research Raises Price Objective to $605 from $600

THOMSON REUTERS
·
Aug 04

Press Release: Vertex Expands Leadership Team to Power the Next Chapter of Growth

Dow Jones
·
Aug 04

Revvity Raises Annual Profit, Revenue Forecasts on Strong Diagnostics Demand

Reuters
·
Aug 04

Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open

Simply Wall St.
·
Aug 04

AI-Driven Lung Cancer Screening Advances Precision Medicine, Boosting Opportunities for TH MEDICAL-B (02697)

Stock News
·
Aug 04

Vertex Pharmaceuticals Inc : TD Cowen Raises Target Price to $550 from $525

THOMSON REUTERS
·
Aug 04

Analysts’ Top Technology Picks: Vertex (VERX), Life360 Shs Chess Depository Interests Repr 3 Sh (LIFX)

TIPRANKS
·
Aug 04

Steris PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 04

Vertex Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Illumina Chief Legal Officer Scott M. Davies Disposes of 615 Common Shares for $123,000

Reuters
·
Aug 04

Fresenius announces FDA approval of rituximab biosimilar

TIPRANKS
·
Aug 04

Vertex Q2 FY26 GAAP Net Income Rises 6% to $1.1 Billion; Revenue Increases 12% to $3.33 Billion

Reuters
·
Aug 04

Vertex Raises Annual Revenue Forecast on Cystic Fibrosis Drugs Strength

Reuters
·
Aug 04

Vertex Pharmaceuticals: Guidance Continues to Include Immaterial Cost Impact from Tariffs in 2026 Based on Currently Known Tariff Rates & Regulations

THOMSON REUTERS
·
Aug 04

Vertex Pharmaceuticals Q2 EPS USD 4.31

THOMSON REUTERS
·
Aug 04